We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Master Gene Found for Intellectual Disability and Epilepsy

By Biotechdaily staff writers
Posted on 22 May 2002
For the first time, researchers have identified a major gene that is responsible for intellectual disability and epilepsy, which often occur together and frequently have genetic causes. More...
Previously nine other epilepsy-causing genes had been identified, belonging predominantly to a specific group called ‘ion channels,' but they have nothing to do with intellectual disability.

"This gene is found on the X-chromosome and is one of probably 100 genes on that chromosome, which when mutated, can cause intellectual disability. The really novel aspect to this gene is its involvement in epilepsy as well as in intellectual disability,” said Dr. Jozef Gecz, from the Department of Cytogenetics and Molecular Genetics of the Women's and Children's Hospital (Adelaide, Australia).

Dr. Gecz explained that the new gene is different, being more of a master gene that controls how, where, and when other genes work and thus contributing to the normal cognitive function of the human brain. "It will be very interesting to know the identity of the genes that are under control of this master gene, as they may potentially be involved in either epilepsy, intellectual disability, or both,” added Dr. Gecz, who led a team of 17 researchers from six collaborating countries. The study was published on March 11, 2002, on the Nature Genetics website.

The researchers studied genetic material from nine families from different parts of the world. They found that the same mutations in the gene gave rise to epilepsy, including early childhood epilepsy and other types of seizures, dystonia, and intellectual disability. It is not yet known why this should occur. Families and isolated cases with ‘nonspecific' intellectual disability may be the main beneficiaries of the identification of this gene. If substantiated by further experiments, the research may speed diagnosis of the disorder that until now was only revealed by delayed development and intellectual impairment.




Related Links:
Women's and Children's Hospital

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Chromogenic Culture System
InTray™ COLOREX™ ECC
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.